Biden Names Geneticist Eric Lander as Top Science Adviser
Biden Names Geneticist Eric Lander as Top Science Adviser
If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.
Biden Names Geneticist Eric Lander as Top Science Adviser
Biden Names Geneticist Eric Lander as Top Science Adviser

If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.

If confirmed, Lander will head the Office of Science and Technology Policy, a position that President Donald Trump left vacant for 18 months at the beginning of his term.

CRISPR patent
A Brief Guide to the Current CRISPR Landscape
A Brief Guide to the Current CRISPR Landscape
Diana Kwon | Jul 15, 2019
Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
USPTO Restarts CRISPR Patent Dispute Between Broad and UC
Jef Akst | Jun 26, 2019
The US patent office declares an interference between the intellectual property held by the Broad Institute and several patent applications filed by the University of California—opposite its previous ruling.
Federal Court Sides with Broad in CRISPR Patent Dispute
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
CRISPR Patent Dispute Heard in Federal Court
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Berkeley CRISPR Inventors Get Another Important European Patent
Berkeley CRISPR Inventors Get Another Important European Patent
Jim Daley | Mar 12, 2018
This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
UC Berkeley: Patent Office “Ignored Key Evidence”
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
Major CRISPR Patent-Holders Agree to Patent Pool
Major CRISPR Patent-Holders Agree to Patent Pool
Aggie Mika | Jul 10, 2017
The Broad Institute and others sign on to participate in a platform designed to streamline the licensing process. 
UC Berkeley Receives CRISPR Patent in Europe
UC Berkeley Receives CRISPR Patent in Europe
Jef Akst | Mar 24, 2017
The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.
Life Science Controversies of 2016
Life Science Controversies of 2016
Bob Grant, Jef Akst, Tracy Vence | Dec 23, 2016
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.
Video: Patent Battle Over CRISPR Gene Editing
Video: Patent Battle Over CRISPR Gene Editing
Jef Akst | Dec 13, 2016
The Scientist goes to court for a CRISPR patent interference case at the US Patent and Trademark Office.
New Developments in CRISPR Patent Case
New Developments in CRISPR Patent Case
Jef Akst | Dec 12, 2016
Documents suggest Feng Zhang started working on CRISPR before Jennifer Doudna’s group published; researchers call for CRISPR technology to be shared openly
CRISPR Oral Arguments Recap, Cont’d
CRISPR Oral Arguments Recap, Cont’d
Jef Akst | Dec 7, 2016
This week’s CRISPR patent hearing took a deep dive into the science of moving the gene-editing technology from prokaryotes to eukaryotic systems.
USPTO to Hear Arguments on CRISPR Patents
USPTO to Hear Arguments on CRISPR Patents
Jef Akst | Dec 5, 2016
Tuesday morning, the US Patent and Trademark Office will hear oral arguments from the two parties that claim to have been the first to use CRISPR-Cas9 gene editing technology in eukaryotic cells.